Cart
sales@molnova.com
Ligustroflavone
CAS No. 260413-62-5
Ligustroflavone( Nuezhenoside )
Catalog No. M18322 CAS No. 260413-62-5
Ligustroflavone has anti-inflammatory activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 148 | In Stock |
|
| 5MG | 92 | In Stock |
|
| 10MG | 155 | In Stock |
|
| 25MG | 262 | In Stock |
|
| 50MG | 369 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLigustroflavone
-
NoteResearch use only, not for human use.
-
Brief DescriptionLigustroflavone has anti-inflammatory activity.
-
DescriptionLigustroflavone has anti-inflammatory activity.
-
In Vitro——
-
In Vivo——
-
SynonymsNuezhenoside
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number260413-62-5
-
Formula Weight724.67
-
Molecular FormulaC33H40O18
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (172.49 mM)
-
SMILESc1(cc(=O)c2c(cc(cc2o1)O[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O[C@@H]1O[C@H]([C@@H]([C@H]([C@H]1O)O)O)C)O)O)CO[C@@H]1O[C@H]([C@@H]([C@H]([C@H]1O)O)O)C)O)c1ccc(cc1)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pieroni A,et al. Isolation and structure elucidation of ligustroflavone, a new apigenin triglycoside from the leaves of Ligustrum vulgare L. Pharmazie. 2000 Jan;55(1):78-80.
molnova catalog
related products
-
Demethoxydeacetoxyps...
Demethoxydeacetoxypseudolaric acid B's the metabolic reaction of TDA in vivo is mainly occurred in blood and contributes to be the hydrolysis of plasma esterase to ester bond, as well as the glucosylation reaction.
-
5-bromo-2-(2,6-dioxo...
5-bromo-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione is a chemical compound.
-
Myosin Kinase Inhibi...
Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) is a substrate-specific peptide inhibitor of MLCK. Myosin light chain kinase fragment 11-19 amide inhibits hypotonicity-induced Ca2+ entry. Myosin light chain kinase fragment 11-19 amide can be used in the research of human cervical cancer.
